Menopause counseling hot flash: Persistent VMS more common in African-Americans and more new research A review of the latest research on the persistence of vasomotor symptoms, the link between hormone therapy and ovarian cancer risk, and the prevalence of substance use in pregnant adolescents. Are common chemicals associated with earlier onset of menopause? February 04, 2015 By Miranda Hester A study of a representative sample of US women shows a clinically significant association between early menopause and exposure to 15 different endocrine-disrupting chemicals. Are severe menopause symptoms a bellwether of bone health? January 29, 2015 By Miranda Hester Women with more severe vasomotor symptoms and night sweats may be at risk of having poorer bone health, according to a prospective observational study. Management of mood and memory problems during menopause Many women complain of changes in their cognitive function during the menopausal transition. Here's how to tell what's normal and what's not--and how to treat appropriately. Untreated hot flashes may impact work productivity September 11, 2014 By Miranda Hester Many women who suffer from moderate to severe vasomotor symptoms (VMS) appear to go untreated, potentially leading to work loss, according to a new study in Menopause. Benefits and risks of postmenopausal hormone therapy: Two expert opinions September 08, 2014 The initial findings from the WHI were concerning, but subsequent detailed analysis and long-term follow-up of women enrolled in these trials have brought perspective. Ultrasound triage of women with postmenopausal bleeding Ultrasound-based evaluation is less costly than an endometrial biopsy and also allows for evaluation of the adnexa and bladder. Caffeine may fuel hot flashes August 07, 2014 By Miranda Hester Menopausal hot flashes may be more bothersome in women who drink caffeine, according to results of a 6-year cross-sectional survey published in Menopause. What’s the impact of hormone therapy on heart health? August 07, 2014 By Miranda Hester According to a recent study in Annals of Internal Medicine, hormonal therapy in early menopause may improve some markers of cardiovascular disease (CVD) risk, but not progression of atherosclerosis. Aromatase inhibitor may improve outcome in premenopausal breast cancer Adjuvant therapy combining ovarian suppression with an aromatase inhibitor—a class of drugs typically only recommended for postmenopausal patients—may be more beneficial for premenopausal patients with breast cancer than tamoxifen.